Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mobilan in Prostate Cancer
NCT02844699Phase 2Unknown
- Sponsor
- Panacela Labs
- Start
- Jul 2016
- Primary completion
- Jan 2018
- Modality
- Gene Editing, Gene Silencing, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of mobilan in prostate cancer (PCa), sponsored by Panacela Labs. Status: unknown.
02
Drugs
mobilan
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02844699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02844699.